English
简体中文
Total: £ 56.28
Published Date: 2026-04-10 | Pages: 123 | Tables: 120 | Pharma & Healthcare
The global Mupirocin Ointment market was valued at US$ 493 million in 2025 and is anticipated to reach US$ 612 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Mupirocin Ointment competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
The mupirocin ointment market is driven by the increasing prevalence of skin infections, including impetigo, as well as the rising incidence of antibiotic-resistant bacterial strains like MRSA (methicillin-resistant Staphylococcus aureus). Mupirocin ointment is widely used as a topical antibiotic for treating various bacterial skin infections, making it an essential product in both hospitals and community healthcare settings. The growing awareness of effective wound care, along with increased healthcare access in developing regions, is also contributing to the demand for mupirocin ointment.
A key challenge in the mupirocin ointment market is the potential for bacterial resistance due to the overuse or misuse of antibiotics, which can reduce the long-term efficacy of the product. Additionally, competition from alternative topical antibiotics and newer antimicrobial therapies could limit market growth. Pricing pressures, particularly in regions with generic product availability, may also impact market share and profitability for branded formulations. Furthermore, stringent regulatory requirements for manufacturing and product approval add to the complexity of market entry for new players.
Currently, global production of Mupirocin Ointment is concentrated as there are few manufacturers engaged in the industry. The largest manufacturer is Glenmark Pharms, who owns 37% revenue market share. As for the region, North America is the largest consumption region, holding 35% revenue market share, followed by China, with 22% market share. Mupirocin Ointment is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria. Among various applications, demand from Retail Pharmacy is the largest sold channel.
This report delivers a comprehensive overview of the global Mupirocin Ointment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Mupirocin Ointment. The Mupirocin Ointment market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Mupirocin Ointment market comprehensively. Regional market sizes by Type, by Sales Channel, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Mupirocin Ointment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Sales Channel, and by region.
Market Segmentation
By Company
Glenmark Pharms
Glaxosmithkline
SmithKline & French
Humanwell Healthcare
Taro Pharmaceutical
Teva
Perrigo
Hanzhou Zhuyangxin Pharmaceutical
GSK
Sun Pharmaceutical
Bausch Health
Segment by Type
Below 10g
10g-20g
Above 20g
by Sales Channel
Hospital
Retail Pharmacy
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Sales Channel, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Mupirocin Ointment manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Mupirocin Ointment sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Sales Channel, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Mupirocin Ointment Market Overview
1.1 Product Definition
1.2 Mupirocin Ointment by Type
1.2.1 Global Mupirocin Ointment Market Value by Type: 2025 vs 2032
1.2.2 Below 10g
1.2.3 10g-20g
1.2.4 Above 20g
1.3 Mupirocin Ointment by Sales Channel
1.3.1 Global Mupirocin Ointment Market Value by Sales Channel: 2025 vs 2032
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Mupirocin Ointment Market Size Estimates and Forecasts
1.4.1 Global Mupirocin Ointment Revenue 2021–2032
1.4.2 Global Mupirocin Ointment Sales 2021–2032
1.4.3 Global Mupirocin Ointment Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Mupirocin Ointment Market Competition by Manufacturers
2.1 Global Mupirocin Ointment Sales Market Share by Manufacturers (2021–2026)
2.2 Global Mupirocin Ointment Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Mupirocin Ointment Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Mupirocin Ointment, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Mupirocin Ointment, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Mupirocin Ointment, Product Types and Applications
2.7 Global Key Manufacturers of Mupirocin Ointment, Date of Entry into the Industry
2.8 Global Mupirocin Ointment Market Competitive Situation and Trends
2.8.1 Global Mupirocin Ointment Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Mupirocin Ointment Players Market Share by Revenue
2.8.3 Global Mupirocin Ointment Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mupirocin Ointment Market Scenario by Region
3.1 Global Mupirocin Ointment Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Mupirocin Ointment Sales by Region: 2021–2032
3.2.1 Global Mupirocin Ointment Sales by Region: 2021–2026
3.2.2 Global Mupirocin Ointment Sales by Region: 2027–2032
3.3 Global Mupirocin Ointment Revenue by Region: 2021–2032
3.3.1 Global Mupirocin Ointment Revenue by Region: 2021–2026
3.3.2 Global Mupirocin Ointment Revenue by Region: 2027–2032
3.4 North America Mupirocin Ointment Market Facts & Figures by Country
3.4.1 North America Mupirocin Ointment Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Mupirocin Ointment Sales by Country (2021–2032)
3.4.3 North America Mupirocin Ointment Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mupirocin Ointment Market Facts & Figures by Country
3.5.1 Europe Mupirocin Ointment Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Mupirocin Ointment Sales by Country (2021–2032)
3.5.3 Europe Mupirocin Ointment Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mupirocin Ointment Market Facts & Figures by Region
3.6.1 Asia Pacific Mupirocin Ointment Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Mupirocin Ointment Sales by Region (2021–2032)
3.6.3 Asia Pacific Mupirocin Ointment Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mupirocin Ointment Market Facts & Figures by Country
3.7.1 Latin America Mupirocin Ointment Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Mupirocin Ointment Sales by Country (2021–2032)
3.7.3 Latin America Mupirocin Ointment Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mupirocin Ointment Market Facts & Figures by Country
3.8.1 Middle East and Africa Mupirocin Ointment Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Mupirocin Ointment Sales by Country (2021–2032)
3.8.3 Middle East and Africa Mupirocin Ointment Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mupirocin Ointment Sales by Type (2021–2032)
4.1.1 Global Mupirocin Ointment Sales by Type (2021–2026)
4.1.2 Global Mupirocin Ointment Sales by Type (2027–2032)
4.1.3 Global Mupirocin Ointment Sales Market Share by Type (2021–2032)
4.2 Global Mupirocin Ointment Revenue by Type (2021–2032)
4.2.1 Global Mupirocin Ointment Revenue by Type (2021–2026)
4.2.2 Global Mupirocin Ointment Revenue by Type (2027–2032)
4.2.3 Global Mupirocin Ointment Revenue Market Share by Type (2021–2032)
4.3 Global Mupirocin Ointment Price by Type (2021–2032)
5 Segment by Sales Channel
5.1 Global Mupirocin Ointment Sales by Sales Channel (2021–2032)
5.1.1 Global Mupirocin Ointment Sales by Sales Channel (2021–2026)
5.1.2 Global Mupirocin Ointment Sales by Sales Channel (2027–2032)
5.1.3 Global Mupirocin Ointment Sales Market Share by Sales Channel (2021–2032)
5.2 Global Mupirocin Ointment Revenue by Sales Channel (2021–2032)
5.2.1 Global Mupirocin Ointment Revenue by Sales Channel (2021–2026)
5.2.2 Global Mupirocin Ointment Revenue by Sales Channel (2027–2032)
5.2.3 Global Mupirocin Ointment Revenue Market Share by Sales Channel (2021–2032)
5.3 Global Mupirocin Ointment Price by Sales Channel (2021–2032)
6 Key Companies Profiled
6.1 Glenmark Pharms
6.1.1 Glenmark Pharms Company Information
6.1.2 Glenmark Pharms Description and Business Overview
6.1.3 Glenmark Pharms Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Glenmark Pharms Mupirocin Ointment Product Portfolio
6.1.5 Glenmark Pharms Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Company Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Glaxosmithkline Mupirocin Ointment Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 SmithKline & French
6.3.1 SmithKline & French Company Information
6.3.2 SmithKline & French Description and Business Overview
6.3.3 SmithKline & French Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SmithKline & French Mupirocin Ointment Product Portfolio
6.3.5 SmithKline & French Recent Developments/Updates
6.4 Humanwell Healthcare
6.4.1 Humanwell Healthcare Company Information
6.4.2 Humanwell Healthcare Description and Business Overview
6.4.3 Humanwell Healthcare Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Humanwell Healthcare Mupirocin Ointment Product Portfolio
6.4.5 Humanwell Healthcare Recent Developments/Updates
6.5 Taro Pharmaceutical
6.5.1 Taro Pharmaceutical Company Information
6.5.2 Taro Pharmaceutical Description and Business Overview
6.5.3 Taro Pharmaceutical Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Taro Pharmaceutical Mupirocin Ointment Product Portfolio
6.5.5 Taro Pharmaceutical Recent Developments/Updates
6.6 Teva
6.6.1 Teva Company Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Mupirocin Ointment Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Perrigo
6.7.1 Perrigo Company Information
6.7.2 Perrigo Description and Business Overview
6.7.3 Perrigo Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Perrigo Mupirocin Ointment Product Portfolio
6.7.5 Perrigo Recent Developments/Updates
6.8 Hanzhou Zhuyangxin Pharmaceutical
6.8.1 Hanzhou Zhuyangxin Pharmaceutical Company Information
6.8.2 Hanzhou Zhuyangxin Pharmaceutical Description and Business Overview
6.8.3 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Product Portfolio
6.8.5 Hanzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
6.9 GSK
6.9.1 GSK Company Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 GSK Mupirocin Ointment Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Sun Pharmaceutical
6.10.1 Sun Pharmaceutical Company Information
6.10.2 Sun Pharmaceutical Description and Business Overview
6.10.3 Sun Pharmaceutical Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Sun Pharmaceutical Mupirocin Ointment Product Portfolio
6.10.5 Sun Pharmaceutical Recent Developments/Updates
6.11 Bausch Health
6.11.1 Bausch Health Company Information
6.11.2 Bausch Health Description and Business Overview
6.11.3 Bausch Health Mupirocin Ointment Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Bausch Health Mupirocin Ointment Product Portfolio
6.11.5 Bausch Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mupirocin Ointment Industry Chain Analysis
7.2 Mupirocin Ointment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mupirocin Ointment Production Mode & Process Analysis
7.4 Mupirocin Ointment Sales and Marketing
7.4.1 Mupirocin Ointment Sales Channels
7.4.2 Mupirocin Ointment Distributors
7.5 Mupirocin Ointment Customer Analysis
8 Mupirocin Ointment Market Dynamics
8.1 Mupirocin Ointment Industry Trends
8.2 Mupirocin Ointment Market Drivers
8.3 Mupirocin Ointment Market Challenges
8.4 Mupirocin Ointment Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Mupirocin Ointment Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Mupirocin Ointment Market Value by Sales Channel (US$ Million), 2025 vs 2032
Table 3. Global Mupirocin Ointment Market Competitive Situation by Manufacturers in 2025
Table 4. Global Mupirocin Ointment Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Mupirocin Ointment Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Mupirocin Ointment Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Mupirocin Ointment Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Mupirocin Ointment Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Mupirocin Ointment, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Mupirocin Ointment, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Mupirocin Ointment, Product Types and Applications
Table 12. Global Key Manufacturers of Mupirocin Ointment, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mupirocin Ointment Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mupirocin Ointment Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mupirocin Ointment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Mupirocin Ointment Sales by Region (K Units), 2021–2026
Table 18. Global Mupirocin Ointment Sales Market Share by Region (2021–2026)
Table 19. Global Mupirocin Ointment Sales by Region (K Units), 2027–2032
Table 20. Global Mupirocin Ointment Sales Market Share by Region (2027–2032)
Table 21. Global Mupirocin Ointment Revenue by Region (US$ Million), 2021–2026
Table 22. Global Mupirocin Ointment Revenue Market Share by Region (2021–2026)
Table 23. Global Mupirocin Ointment Revenue by Region (US$ Million), 2027–2032
Table 24. Global Mupirocin Ointment Revenue Market Share by Region (2027–2032)
Table 25. North America Mupirocin Ointment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Mupirocin Ointment Sales by Country (K Units), 2021–2026
Table 27. North America Mupirocin Ointment Sales by Country (K Units), 2027–2032
Table 28. North America Mupirocin Ointment Revenue by Country (US$ Million), 2021–2026
Table 29. North America Mupirocin Ointment Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Mupirocin Ointment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Mupirocin Ointment Sales by Country (K Units), 2021–2026
Table 32. Europe Mupirocin Ointment Sales by Country (K Units), 2027–2032
Table 33. Europe Mupirocin Ointment Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Mupirocin Ointment Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Mupirocin Ointment Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Mupirocin Ointment Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Mupirocin Ointment Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Mupirocin Ointment Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Mupirocin Ointment Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Mupirocin Ointment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Mupirocin Ointment Sales by Country (K Units), 2021–2026
Table 42. Latin America Mupirocin Ointment Sales by Country (K Units), 2027–2032
Table 43. Latin America Mupirocin Ointment Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Mupirocin Ointment Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Mupirocin Ointment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Mupirocin Ointment Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Mupirocin Ointment Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Mupirocin Ointment Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Mupirocin Ointment Revenue by Country (US$ Million), 2027–2032
Table 50. Global Mupirocin Ointment Sales (K Units) by Type (2021–2026)
Table 51. Global Mupirocin Ointment Sales (K Units) by Type (2027–2032)
Table 52. Global Mupirocin Ointment Sales Market Share by Type (2021–2026)
Table 53. Global Mupirocin Ointment Sales Market Share by Type (2027–2032)
Table 54. Global Mupirocin Ointment Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Mupirocin Ointment Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Mupirocin Ointment Revenue Market Share by Type (2021–2026)
Table 57. Global Mupirocin Ointment Revenue Market Share by Type (2027–2032)
Table 58. Global Mupirocin Ointment Price (US$/Unit) by Type (2021–2026)
Table 59. Global Mupirocin Ointment Price (US$/Unit) by Type (2027–2032)
Table 60. Global Mupirocin Ointment Sales (K Units) by Sales Channel (2021–2026)
Table 61. Global Mupirocin Ointment Sales (K Units) by Sales Channel (2027–2032)
Table 62. Global Mupirocin Ointment Sales Market Share by Sales Channel (2021–2026)
Table 63. Global Mupirocin Ointment Sales Market Share by Sales Channel (2027–2032)
Table 64. Global Mupirocin Ointment Revenue (US$ Million) by Sales Channel (2021–2026)
Table 65. Global Mupirocin Ointment Revenue (US$ Million) by Sales Channel (2027–2032)
Table 66. Global Mupirocin Ointment Revenue Market Share by Sales Channel (2021–2026)
Table 67. Global Mupirocin Ointment Revenue Market Share by Sales Channel (2027–2032)
Table 68. Global Mupirocin Ointment Price (US$/Unit) by Sales Channel (2021–2026)
Table 69. Global Mupirocin Ointment Price (US$/Unit) by Sales Channel (2027–2032)
Table 70. Glenmark Pharms Company Information
Table 71. Glenmark Pharms Description and Business Overview
Table 72. Glenmark Pharms Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Glenmark Pharms Mupirocin Ointment Product
Table 74. Glenmark Pharms Recent Developments/Updates
Table 75. Glaxosmithkline Company Information
Table 76. Glaxosmithkline Description and Business Overview
Table 77. Glaxosmithkline Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Glaxosmithkline Mupirocin Ointment Product
Table 79. Glaxosmithkline Recent Developments/Updates
Table 80. SmithKline & French Company Information
Table 81. SmithKline & French Description and Business Overview
Table 82. SmithKline & French Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. SmithKline & French Mupirocin Ointment Product
Table 84. SmithKline & French Recent Developments/Updates
Table 85. Humanwell Healthcare Company Information
Table 86. Humanwell Healthcare Description and Business Overview
Table 87. Humanwell Healthcare Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Humanwell Healthcare Mupirocin Ointment Product
Table 89. Humanwell Healthcare Recent Developments/Updates
Table 90. Taro Pharmaceutical Company Information
Table 91. Taro Pharmaceutical Description and Business Overview
Table 92. Taro Pharmaceutical Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Taro Pharmaceutical Mupirocin Ointment Product
Table 94. Taro Pharmaceutical Recent Developments/Updates
Table 95. Teva Company Information
Table 96. Teva Description and Business Overview
Table 97. Teva Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Teva Mupirocin Ointment Product
Table 99. Teva Recent Developments/Updates
Table 100. Perrigo Company Information
Table 101. Perrigo Description and Business Overview
Table 102. Perrigo Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Perrigo Mupirocin Ointment Product
Table 104. Perrigo Recent Developments/Updates
Table 105. Hanzhou Zhuyangxin Pharmaceutical Company Information
Table 106. Hanzhou Zhuyangxin Pharmaceutical Description and Business Overview
Table 107. Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Product
Table 109. Hanzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
Table 110. GSK Company Information
Table 111. GSK Description and Business Overview
Table 112. GSK Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. GSK Mupirocin Ointment Product
Table 114. GSK Recent Developments/Updates
Table 115. Sun Pharmaceutical Company Information
Table 116. Sun Pharmaceutical Description and Business Overview
Table 117. Sun Pharmaceutical Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Sun Pharmaceutical Mupirocin Ointment Product
Table 119. Sun Pharmaceutical Recent Developments/Updates
Table 120. Bausch Health Company Information
Table 121. Bausch Health Description and Business Overview
Table 122. Bausch Health Mupirocin Ointment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Bausch Health Mupirocin Ointment Product
Table 124. Bausch Health Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Mupirocin Ointment Distributors List
Table 128. Mupirocin Ointment Customers List
Table 129. Mupirocin Ointment Market Trends
Table 130. Mupirocin Ointment Market Drivers
Table 131. Mupirocin Ointment Market Challenges
Table 132. Mupirocin Ointment Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mupirocin Ointment
Figure 2. Global Mupirocin Ointment Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Mupirocin Ointment Market Share by Type: 2025 & 2032
Figure 4. Below 10g Product Picture
Figure 5. 10g-20g Product Picture
Figure 6. Above 20g Product Picture
Figure 7. Global Mupirocin Ointment Market Value by Sales Channel (US$ Million), 2021–2032
Figure 8. Global Mupirocin Ointment Market Share by Sales Channel: 2025 & 2032
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Others
Figure 12. Global Mupirocin Ointment Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Mupirocin Ointment Market Size (US$ Million), 2021–2032
Figure 14. Global Mupirocin Ointment Sales (K Units), 2021–2032
Figure 15. Global Mupirocin Ointment Average Price (US$/Unit), 2021–2032
Figure 16. Mupirocin Ointment Report Years Considered
Figure 17. Mupirocin Ointment Sales Share by Manufacturers in 2025
Figure 18. Global Mupirocin Ointment Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Mupirocin Ointment Players: Market Share by Revenue in Mupirocin Ointment in 2025
Figure 20. Mupirocin Ointment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Mupirocin Ointment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Mupirocin Ointment Sales Market Share by Country (2021–2032)
Figure 23. North America Mupirocin Ointment Revenue Market Share by Country (2021–2032)
Figure 24. United States Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Mupirocin Ointment Sales Market Share by Country (2021–2032)
Figure 27. Europe Mupirocin Ointment Revenue Market Share by Country (2021–2032)
Figure 28. Germany Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Mupirocin Ointment Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Mupirocin Ointment Revenue Market Share by Region (2021–2032)
Figure 35. China Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Latin America Mupirocin Ointment Sales Market Share by Country (2021–2032)
Figure 45. Latin America Mupirocin Ointment Revenue Market Share by Country (2021–2032)
Figure 46. Mexico Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Brazil Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Argentina Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Mupirocin Ointment Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Mupirocin Ointment Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Mupirocin Ointment Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Mupirocin Ointment by Type (2021–2032)
Figure 55. Global Revenue Market Share of Mupirocin Ointment by Type (2021–2032)
Figure 56. Global Mupirocin Ointment Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Mupirocin Ointment by Sales Channel (2021–2032)
Figure 58. Global Revenue Market Share of Mupirocin Ointment by Sales Channel (2021–2032)
Figure 59. Global Mupirocin Ointment Price (US$/Unit) by Sales Channel (2021–2032)
Figure 60. Mupirocin Ointment Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
